The Lupus Foundation of America describes lupus as a chronic disease that attacks the immune system, the part of the body ...

After a previously reported positive phase 2 trial in systemic lupus erythematosus (SLE), the TYK2 inhibitor deucravacitinib ...

Lupus is an autoimmune condition that can cause pain, problems in multiple organs and systems of the body, inflammation, and complications that range from minor to life threatening. The body’s ...

Most people with lupus have some type of skin problems, such as a lupus rash or other changes to the skin. Based on the type ...

The history of lupus can be divided into three periods: classical, neoclassical, and modern. This article concentrates on developments in the present century which have greatly expanded our knowledge ...

Lupus Alert Day serves a vital purpose. It encourages others to learn more about lupus, share information on social media, ...

Cutaneous vasculitis (CV) is a term used for inflammation of the blood vessels in the skin that occurs in up to 70% of patients with lupus erythematosus (LE). The inflammation affects the smaller ...

More than one-third of patients with systemic lupus erythematosus experience a flare after starting dialysis for end-stage ...

Please provide your email address to receive an email when new articles are posted on . Chimeric antigen receptor T-cell therapy improves not only lupus disease activity but also other related ...